Welcome to LookChem.com Sign In|Join Free

CAS

  • or

685513-89-7

Post Buying Request

685513-89-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

685513-89-7 Usage

General Description

1H-Pyrrolo[2,3-b]pyridine, 4,5-difluoro-1-[tris(1-methylethyl)silyl]- is a chemical compound that belongs to the class of pyrrolopyridines. It comprises a pyrrolopyridine core with two fluorine atoms and a tris(1-methylethyl)silyl group attached at specific positions. 1H-Pyrrolo[2,3-b]pyridine, 4,5-difluoro-1-[tris(1-methylethyl)silyl]- has potential applications in organic synthesis, pharmaceuticals, and materials science. Its unique structure and properties make it a valuable building block in the development of novel compounds and materials for various industrial and research purposes.

Check Digit Verification of cas no

The CAS Registry Mumber 685513-89-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,8,5,5,1 and 3 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 685513-89:
(8*6)+(7*8)+(6*5)+(5*5)+(4*1)+(3*3)+(2*8)+(1*9)=197
197 % 10 = 7
So 685513-89-7 is a valid CAS Registry Number.
InChI:InChI=1/C16H24F2N2Si/c1-10(2)21(11(3)4,12(5)6)20-8-7-13-15(18)14(17)9-19-16(13)20/h7-12H,1-6H3

685513-89-7Downstream Products

685513-89-7Relevant articles and documents

Compound serving as protein kinase inhibitor and application of compound

-

, (2021/04/07)

The invention discloses a compound used as a protein kinase inhibitor and application of the compound, the compound has an obvious inhibition effect on protein kinase activity, can be used as a BTK inhibitor for preparing medicines for treating BTK-mediated diseases such as malignant tumors, autoimmune diseases and the like, and has wide application prospect.

OXADIAZINE COMPOUNDS AND METHODS OF USE THEREOF

-

, (2017/03/14)

The present disclosure relates to oxadiazine compounds, pharmaceutical compositions comprising an effective amount of an oxadiazine compound and methods for using an oxadiazine compound in the treatment of a neurodegenerative disease, comprising administering to a subject in need thereof an effective amount of an oxadiazine compound.

PYRROLOPYRIDINES AS KINASE INHIBITORS

-

Page/Page column 100-101, (2009/12/23)

Compounds of Formula (I) are useful for inhibition of CHKl and/or CHK2. Methods of using compounds of Formula (I) and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 685513-89-7